Welcome to the Newron Pharmaceuticals website.
We are a clinical-stage biopharmaceutical company.
Our shares are listed on the SIX Swiss Exchange (NWRN).
Our mission is to discover, develop and commercialise novel drugs to treat
diseases of the Central Nervous System (CNS) and pain.
May 21-22, 2014 - Hilton Amsterdam Hotel, Amsterdam - The Netherlands
April 8, 2014 - Kongresshaus, Gotthardstrasse 5, Zürich - Switzerland
March 27, 2014 at 10.30am - @ the registered office of the Company, Via Ludovico Ariosto n. 21 in Bresso (MI) - Italy